Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-010920
Filing Date
2025-08-08
Accepted
2025-08-08 16:05:51
Documents
61
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20250630x10q.htm   iXBRL 10-Q 1723067
2 EX-31.1 tmb-20250630xex31d1.htm EX-31.1 15724
3 EX-32.1 tmb-20250630xex32d1.htm EX-32.1 7013
  Complete submission text file 0001558370-25-010920.txt   5736903

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20250630.xsd EX-101.SCH 51096
5 EX-101.CAL tmb-20250630_cal.xml EX-101.CAL 32284
6 EX-101.DEF tmb-20250630_def.xml EX-101.DEF 195877
7 EX-101.LAB tmb-20250630_lab.xml EX-101.LAB 337985
8 EX-101.PRE tmb-20250630_pre.xml EX-101.PRE 288271
64 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20250630x10q_htm.xml XML 691179
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38191 | Film No.: 251198379
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)